[Edaily Starin KIM HYUNSIK Reporter] Singer Kim Gun-mo is making a comeback with a new album. (Photo courtesy of Geonum Planning)According to his agency, Geonum Planning, on the 25th, Kim Gun-mo will release a single featuring his new song “Where Am I Headed?” via various online music platforms at 6 p.m. on the 1st of next month. This marks Kim Gun-mo’s first new release in about 10 years, following his 2016 25th-anniversary album “50.” Previously, Kim Gun-mo had completely suspended his activities after being accused of sexual assault by a woman identified as Ms. A in 2019. At the time, Ms. A alleged that Kim Gun-mo had sexually assaulted her at a bar in Gangnam-gu, Seoul, in 2016. The Seoul Central District Prosecutors’ Office, which investigated the case, concluded in November 2021 that the allegations were not substantiated and decided not to indict him. Ms. A filed an appeal, but the Seoul High Prosecutors’ Office again decided not to indict him. (Photo courtesy of Geonum Entertainment)
After a long hiatus, Kim Gun-mo resumed his music career through a nationwide concert tour held from September of last year through March of this year in cities including Busan, Daegu, Daejeon, and Seoul. On stage during the tour, Kim Gun-mo stated, “I will prepare a new album with the mindset of making my debut all over again.” His new song, “Where Am I Going?”, is a remake of the song of the same name released by Jeon Young in 1977. An agency representative said, “Kim Gun-mo temporarily set aside his familiar image as ‘Kim Gun-mo, the pianist’ and sang while playing the guitar himself,” adding, “This song will mark the second starting point of Kim Gun-mo’s musical career.”
Jeonbuk Bank, a subsidiary of JB Financial Group Co., Ltd.(175330), has become the first bank in South Korea to introduce won-denominated loans linked to digital assets. Initially, the service will be…
GENINUS Inc.(389030)is embarking on experimental research to verify the feasibility of developing actual treatments based on new anti-cancer drug targets identified using artificial intelligence (AI).…
#Onconic Therapeutics Inc. has unveiled a new drug candidate designed to reduce muscle loss that can occur during weight loss when used in combination with existing glucagon-like peptide-1 (GLP-1) cla…